logo
Ukrainian doctor drives a child's heart through Russian attack to perform a life-saving transplant

Ukrainian doctor drives a child's heart through Russian attack to perform a life-saving transplant

CNN11-07-2025
Kyiv was burning as Dr. Borys Todurov sped through the city in an ambulance, undeterred by the deep thuds of explosions and the terrifying sounds of Russian drones flying overhead.
He was determined to deliver his precious cargo: a human heart.
Todurov's patient – a child – was seriously ill in a hospital. He had hours to act.
The child has been living with a heart disease for several years, but her condition deteriorated earlier this week and Todurov knew a new heart was her only chance.
So when one became available from a child donor on the opposite side of the city, he didn't wait for the Russians to stop attacking.
Russia has ramped up its aerial attacks against Ukraine in recent weeks. It fired more than 400 drones and 18 missiles, including eight ballistic and six cruise missiles overnight into Thursday.
As the Ukrainian authorities called on people to hide in bomb shelters and basements, Todurov and his staff made the 10-mile drive from the Okhmatdyt children's hospital in western Kyiv to the city's Heart Institute on the eastern bank of the river while missiles and drones were flying around.
While the Ukrainian Air Force managed to shoot down or disable the vast majority of the drones and missiles, two people were killed and dozens more injured in the attack on Thursday.
Thursday's mass attack on Kyiv was just the latest in a deadly string of Russian assaults. Just the day before, Moscow launched more than 700 drones – a new record – against Ukraine on a single night.
Todurov, the director of the Heart Institute, and his team worked non-stop throughout the two nights of attacks.
After performing a heart surgery at the institute on Wednesday, he traveled across the city to Okhmatdyt where he removed the heart from the body of the donor.
He then personally escorted the organ across the city.
Crossing the Dnipro by a bridge is extremely dangerous during an attack on Kyiv, because vehicles are exposed and Ukrainian air defences target Russian drones and missiles when they are above the river to minimise the impact from falling debris.
A video taken during the frantic drive shows a large fire burning near the road as Todurov drives on. 'We're carrying a heart,' he says calmly.
The Russian attack on the capital was still underway when Todurov got into the operating theater at the Heart Institute, heading a large medical team and transplanting the heart into the body of his patient.
In a stunning moment captured on camera and shared with CNN, the new heart is seen beating inside the patient's chest, just hours after it was driven through Kyiv as Russian drones and missiles rained down on the city.
'The heart is working, and the pressure is stable. We hope that … (the patient) will recover and live a long and full life,' the doctor said.
The Ukrainian Transplant Coordination Centre said in a statement that the donor was a four-year-old girl who was declared brain-dead by a medical council after suffering serious injuries.
The girl's mother, herself a medical worker, agreed to have her daughter's organs donated.
And so, just as Todurov was transplanting the girl's heart into his patient's body at the Heart Institute, her kidneys were being transplanted to a 14-year-old boy and her liver to a 16-year-old girl, the center said. The two other patients were at the Okhmatdyt hospital, so no transport was required to get the organs to them.
The coordination center said that two of the three recipients were in critical condition and had they not received the transplants, they would have just days or weeks to live.
'May the little donor rest in peace. Our condolences to her family and gratitude for their difficult but important decision,' the center said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Enterosorbent Gel Shows Efficacy in IBS
Enterosorbent Gel Shows Efficacy in IBS

Medscape

timea day ago

  • Medscape

Enterosorbent Gel Shows Efficacy in IBS

TOPLINE: Silicolgel, a colloidal silicic acid enterosorbent, was generally safe and well tolerated, and it significantly reduced symptom severity in adults with irritable bowel syndrome, with efficacy being observed in both patients with predominant diarrhoea (IBS-D) and those with mixed bowel habits (IBS-M). METHODOLOGY: Researchers conducted a randomised controlled trial to assess the efficacy, safety, and tolerability of silicolgel in patients with IBS-D and IBS-M. They included 120 adults (mean age, 36.9 years; 66% women) with IBS-D or IBS-M across four regional health centres in Ukraine between March 15, 2023, and August 31, 2023, with a score on the IBS Severity Scoring System (IBS-SSS) of 100-400 points. Patients were randomly assigned to receive either 15 mL of silicolgel (n = 60) or placebo (n = 60) three times daily for 4 weeks, followed by a 4-week no-medication observation phase to assess the return of symptoms. The primary outcome was a reduction in IBS-SSS scores by ≥ 50 points after 4 weeks of treatment, indicating a clinically meaningful improvement in symptoms. Patients used daily diaries to track bowel habits, IBS symptoms (including abdominal pain and bloating), and quality of life. TAKEAWAY: After 4 weeks, the proportion of patients achieving at least a 50-point reduction in the IBS-SSS score was significantly higher in the silicolgel group than in the placebo group (91.67% vs 20%; relative risk [RR], 4.58; P < .0001). The silicolgel group showed a significantly greater decrease in the mean IBS-SSS score, from 255.62 at baseline to 92.75 after 4 weeks, than the placebo group that showed a change from 254.42 at baseline to 257.58 after 4 weeks (P < .001). Among patients with IBS-D and IBS-M, those on silicolgel vs placebo achieved the primary outcome (RR, 4.77 and 4.44, respectively; P < .0001 for both). Significant reductions in mean severity scores were noted for IBS symptoms from baseline to week 4 with silicolgel. All adverse events were mild and non-serious, noted at one site, and found unrelated to treatment, with no treatment discontinuations observed. IN PRACTICE: "Silicolgel is a widely available and affordable enterosorbent treatment, providing safe and effective relief of symptoms in patients with IBS-D and IBS-M. Based on these findings, its use should be considered more widely for frontline therapy of IBS-D and IBS-M," the authors of the study wrote. SOURCE: This study was led by O. Kuzminska, Chernivtsi Hospital of Emergency Medical Care, Chernivtsi, Ukraine. It was published online on July 25, 2025, in Neurogastroenterology & Motility. LIMITATIONS: Silicolgel is not absorbed and works locally in the gut, beginning to exert its effect immediately. Thickeners could not be used in the placebo because they affect the gut, so the viscosity of the placebo was a white, watery solution. Additionally, the treatment was limited to 28 days as silicolgel's licence permits a continuous dosing period of not more than 4 weeks. DISCLOSURES: This study was supported by FW Medical Ltd, the owner of silicolgel, and Delta Medical LLC, the distributor of silicolgel in Ukraine. They had no direct involvement in the study. One author reported being a consultant for the owner company. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

North Texas surgeons working in Ukraine to ease "in-the-mirror" reminders of war
North Texas surgeons working in Ukraine to ease "in-the-mirror" reminders of war

CBS News

time2 days ago

  • CBS News

North Texas surgeons working in Ukraine to ease "in-the-mirror" reminders of war

It's been more than three years since Russia invaded Ukraine. The bombs are still dropping and even those that survive will never be the same. "Once you see war firsthand, it just, it's so sad," said Dallas oculoplastic surgeon Dr. Jorge Corona. "Because it's not just the soldiers and their families that suffer, but the whole country." Corona is a part of a group of North Texans tapping a combination of technology, surgical skill and compassion to ease the "in-the-mirror" reminders of war, with ocular facial reconstruction for wounded soldiers and civilians. "It's incredible how sad it is to see them, their faces destroyed," said Corona. "But, by restoring their faces, we feel that we are restoring their humanity." For most, the horrors of war have never been any closer than video clips. But for Corona, the mission became one of moral principles. "Well, when you look at history, in 1939, Nazi Germany invaded Europe," said Corona. "Now we are in the 21st century, and the same thing is happening with Russia invading Ukraine. I'm not a soldier. But I didn't want to stay on the sidelines." Wielding a scalpel instead of a weapon, Corona and the team were often forced to retreat to bomb shelters but made the most of every moment. Following a three-hour surgery, a Ukrainian soldier's face has been rebuilt using a titanium implant manufactured in North Texas at MedCAD. "MedCAD is a patient-specific medical device company and everything we make is for one patient for one surgery," said MedCAD President and CEO Nancy Hairston. Hairston said the process begins with patient CT data sent from Ukraine. "And from there, we design a surgical kit that includes implants and surgical devices that allow them to kind of get in and get out when they're in the OR most efficiently as possible to provide the best, the most optimal type of reconstruction that's possible," said Hairston. Organizers say the Plano manufacturing facility is where "science meets art", but it's clear that compassion is the driving force. "I mean, it's just incredible to see how this will be in their lives forever," Corona said. "And these individuals that we're working with are getting, their, as Jorge said, their humanity back," said Hairston. "That they can look in the mirror and not have that reminder that they were in a horribly traumatic situation. And it's very moving for our team to learn and hear the stories. It's sort of buoys everybody's day to hear that we've made such a difference."

CTA Red Line service suspended on Chicago's North Side
CTA Red Line service suspended on Chicago's North Side

CBS News

time3 days ago

  • CBS News

CTA Red Line service suspended on Chicago's North Side

Red Line service was suspended on Chicago's North Side early Wednesday morning. According to the CTA, Howard and Belmont's service was stopped due to a medical emergency. Trains are operating only between 95th and Belmont. The CTA said shuttle buses have been requested to provide connecting service through the affected area. Commuters are advised to seek alternate routes. This is a developing story. CBS News Chicago will continue to provide updates.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store